Overview
Steven Wallentine is a Hematologist Oncology specialist and a Hematologist in Provo, Utah. Dr. Wallentine is rated as an Experienced provider by MediFind in the treatment of Leukocytosis. His top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Non-Hodgkin Lymphoma, and Thrombocytopenia. Dr. Wallentine is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- PPO
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Provo, UT 84604
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Utah Adult Services
Josef Prchal is a Hematologist and an Oncologist in Salt Lake City, Utah. Dr. Prchal is rated as an Elite provider by MediFind in the treatment of Leukocytosis. His top areas of expertise are Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, Myeloproliferative Neoplasms (MPN), and Bone Marrow Transplant. Dr. Prchal is currently accepting new patients.
Intermountain Health Cancer Center - Utah Valley
"Sohaip Kabashneh, MD is a dedicated hematology/oncology physician at Intermountain Health�s Cancer Center � Utah Valley in Provo, Utah. He supports patients in Provo, Orem, Vineyard, Springville, and surrounding communities providing care in breast cancer, lung cancer, prostate cancer, gastrointestinal cancers, and more. He is excited to bring his specialties in medical oncology, benign hematology, and malignant hematology to his patients at Intermountain Health.�His philosophy of care is rooted in the belief that ""The good physician treats the disease; the great physician treats the patient who has the disease."" This principle guides his approach to patient care. Dr. Kabashneh is rated as an Experienced provider by MediFind in the treatment of Leukocytosis. His top areas of expertise are Leukocytosis, Scleromyxedema, Papular Mucinosis, Mesenteric Venous Thrombosis, and Coronary Artery Bypass Graft (CABG).
Utah Cancer Specialists - Provo
William Stephenson is a Hematologist Oncology provider in Provo, Utah. Dr. Stephenson has been practicing medicine for over 36 years and is rated as a Distinguished provider by MediFind in the treatment of Leukocytosis. His top areas of expertise are Drug-Induced Thrombocytopenia, Thrombocytopenia, Hemochromatosis, and Richter Syndrome. Dr. Stephenson is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Lymphocytic Leukemia (CLL)Dr. Wallentine isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Colorectal CancerDr. Wallentine isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Wallentine isDistinguished. Learn about Familial Colorectal Cancer.
- Inflammatory Breast CancerDr. Wallentine isDistinguished. Learn about Inflammatory Breast Cancer.
- Non-Hodgkin LymphomaDr. Wallentine isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Ovarian CarcinosarcomaDr. Wallentine isDistinguished. Learn about Ovarian Carcinosarcoma.
- Advanced
- Adult Immune ThrombocytopeniaDr. Wallentine isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Wallentine isAdvanced. Learn about Agranulocytosis.
- Breast CancerDr. Wallentine isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Wallentine isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Wallentine isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Familial NeutropeniaDr. Wallentine isAdvanced. Learn about Chronic Familial Neutropenia.
- Experienced
- Acute Mountain SicknessDr. Wallentine isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with MaturationDr. Wallentine isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without MaturationDr. Wallentine isExperienced. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Wallentine isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Wallentine isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Wallentine isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.